Arbutus Biopharma Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arbutus Biopharma

ABUS 4.730

-2.3%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: donpat	4/15/2014 3:05:32 PM
	of 42

Tekmira Pharmaceuticals Corp Coverage Initiated by Analysts at RBC Capital (TKMR) Posted by Ethan Ryder on Apr 15th, 2014 Tekmira Pharmaceuticals Corp logoAnalysts at RBC Capital assumed coverage on shares of Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) in a research report issued to clients and investors on Friday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $30.00 price target on the stock. RBC Capital’s price objective suggests a potential upside of 101.75% from the stock’s previous close. A number of other firms have also recently commented on TKMR. Analysts at Maxim Group raised their price target on shares of Tekmira Pharmaceuticals Corp from $17.00 to $31.00 in a research note on Monday, February 24th. They now have a “buy” rating on the stock. Analysts at Stifel Nicolaus initiated coverage on shares of Tekmira Pharmaceuticals Corp in a research note on Friday, January 31st. They set a “buy” rating and a $19.00 price target on the stock. Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) opened at 14.87 on Friday. Tekmira Pharmaceuticals Corp has a 52-week low of $4.46 and a 52-week high of $31.48. The stock has a 50-day moving average of $23.19 and a 200-day moving average of $13.4. Tekmira is a leader in the development of therapeutic agents based upon Nobel Prize winning breakthroughs in the field of gene silencing, known as RNA interference (NASDAQ:TKMR). tickerreport.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next